v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 1,925,450 $ 2,702,697
Adjustments to reconcile net income to net cash provided by operating activities:    
Impairment of goodwill and purchased intangible assets 289,474 0
Depreciation and amortization 300,729 310,300
Loss on extinguishment of debt 0 13,286
Unrealized foreign exchange gain and other (16,747) (35,427)
Asset impairment charges 0 9,905
Disposal of non-controlling interest 0 8,270
Stock-based compensation expense 154,074 121,517
Gain on sale of business 0 (29,687)
Deferred income taxes (124,594) (321,712)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable 141,064 (153,630)
Inventories (131,249) (604,393)
Other assets (223,625) (30,427)
Accounts payable 799 (38,817)
Deferred system revenue 342,749 32,822
Deferred service revenue 129,010 35,551
Other liabilities (371,174) 690,435
Net cash provided by operating activities 2,415,960 2,710,690
Cash flows from investing activities:    
Proceeds from sale of assets 5,079 0
Net proceeds from sale of business 0 75,358
Business acquisitions, net of cash acquired (3,682) (27,144)
Capital expenditures (216,639) (262,908)
Purchases of available-for-sale and equity securities (2,154,906) (960,837)
Proceeds from sale of available-for-sale securities 70,957 74,541
Proceeds from maturity of available-for-sale securities 971,085 699,363
Purchases of trading securities (112,463) (77,759)
Proceeds from sale of trading securities 102,376 70,279
Proceeds from other investments 0 1,020
Net cash used in investing activities (1,338,193) (408,087)
Cash flows from financing activities:    
Payment of debt issuance costs 0 (6,515)
Proceeds from issuance of debt, net of issuance costs 735,043 0
Proceeds from revolving credit facility 0 300,000
Repayment of debt 0 (1,087,250)
Common stock repurchases (1,265,480) (923,039)
Payment of dividends to stockholders (575,520) (553,046)
Issuance of common stock 48,433 33,908
Tax withholding payments related to vested and released restricted stock units (95,516) (73,704)
Contingent consideration payable and other, net (4,116) (5,027)
Purchase of non-controlling interest 0 (4,295)
Net cash used in financing activities (1,157,156) (2,318,968)
Effect of exchange rate changes on cash and cash equivalents (309) (30)
Net decrease in cash and cash equivalents (79,698) (16,395)
Cash and cash equivalents at beginning of period 1,927,865 1,584,908
Cash and cash equivalents at end of period 1,848,167 1,568,513
Supplemental cash flow disclosures:    
Income taxes paid, net 765,282 451,243
Interest paid 251,426 198,906
Non-cash activities:    
Contingent consideration payable - financing activities (765) (1,849)
Dividends payable - financing activities 6,090 5,856
Unsettled common stock repurchase - financing activities 10,999 15,943
Accrued purchases of land, property and equipment - investing activities $ 15,378 $ 14,390

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL